Skip to main content

Table 1 2D structures of the Chromen-2-one derivatives and their experimental pIC50

From: Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen-2-ones analogues as anti-cancer agents

  1. TTest set